Welcome
Support Centre
23 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Changing illness perceptions of patients with intermittent claudication
ISRCTN ISRCTN28051878
ClinicalTrials.gov identifier
Public title Changing illness perceptions of patients with intermittent claudication
Scientific title Changing illness perceptions of patients with intermittent claudication: a pilot randomised controlled trial to increase walking
Acronym N/A
Serial number at source N/A
Study hypothesis Principal research question:
Will a brief psychological intervention to modify illness perceptions increase walking behaviour for patients with intermittent claudication?

Secondary research questions:
1. Will a brief psychological intervention increase intention to walk?
2. Will a brief psychological intervention increase walking self-efficacy?
3. Will a brief psychological intervention change illness perceptions?

As of 03/11/2009 this record was updated to include an extended anticipated end date; the initial anticipated end date at the time of registration was 01/10/2009.

As of 13/01/2010 this record was updated to include a further extended anticipated end date; the previous anticipated end date at the time of registration was 30/11/2009.
Lay summary Not provided at time of registration
Ethics approval Fife and Forth Valley NHS Research Ethics Committee approved on the 12th February 2008 (ref: 08/S0501/6).
Study design Single-centre randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Intermittent claudication
Participants - inclusion criteria 1. Newly diagnosed patients with intermittent claudication
2. English speaking
3. Aged over 55 years, either sex
Participants - exclusion criteria 1. Severe cardiac disease
2. Patients unable to perform simple exercise test at slow speed
3. Severe debility, e.g., arthritis
4. History of orthopaedic surgery
5. Ankle Brachial Blood Pressure Index (ABPI) at diagnosis of less than 0.35
Anticipated start date 07/04/2008
Anticipated end date 01/02/2012
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 80
Interventions Session 1: one hour in the participant's own home:
1. Modify illness beliefs regarding interpretation of symptoms and chronicity of disease by providing information about disease, and behaviour health link
2. Modify understanding of consequences of disease and future health risk perception by providing information on consequences of disease
3. Operationalise above points 1 and 2 using motivational interviewing

Session 2: one hour in the participant's own home:
4. Improve personal control/self efficacy by prompting specific goal setting for walking; prompt barrier identification to formulate a coping plan

Three follow up phone calls (monthly):
5. Prompt review of behavioural goals through monthly phone calls
6. Provide social support through the inclusion in the intervention of a key partner

Control:
Control group receives usual care and phone calls to minimise social support effects.

Total duration of treatment is 2 hours. Follow-up for both arms is at 4 months, however an amendment to ethical approval has been submitted to carry out long-term follow-ups at 1 year and 2 years after recruitment.
Primary outcome measure(s) Increase in walking behaviour as measured by pedometer (mean daily steps measured over 1 week at each time point) at baseline, 4 months, and 1 year and 2 years (subject to the approval of the amendment).
Secondary outcome measure(s) All outcomes will be measured at baseline, 4 months, and 1 year and 2 years (subject to the approval of the amendment):
1. Self-report physical activity, measured with the International Physical Activity Questionnaire (IPAQ)
2. Quality of life, measured with the Intermittent Claudication Questionnaire (ICQ)
3. Psychological outcomes, measured with a range of psychological questionnaires adapted for use in this study
4. Clinical outcome, measured by type of treatment received or scheduled by each time point e.g. angioplasty, bypass graft, conservative treatment
Sources of funding University of Stirling (UK) - Internally funded PhD
Trial website
Publications 1. 2010 protocol in http://www.ncbi.nlm.nih.gov/pubmed/20929555
2. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/22038532
Contact name Ms  Margaret  Cunningham
  Address Psychology Department
University of Stirling
  City/town Stirling
  Zip/Postcode FK9 4LA
  Country United Kingdom
Sponsor University of Stirling (UK)
  Address Head of Psychology Department
Psychology Department
  City/town Stirling
  Zip/Postcode FK9 4LA
  Country United Kingdom
  Sponsor website: http://www.stir.ac.uk/
Date applied 01/04/2008
Last edited 25/01/2012
Date ISRCTN assigned 28/10/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central